Gawęda, W.; Pruszyński, M.; Cędrowska, E.; Rodak, M.; Majkowska-Pilip, A.; Gaweł, D.; Bruchertseifer, F.; Morgenstern, A.; Bilewicz, A.
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials 2020, 10, 2067.
https://doi.org/10.3390/nano10102067
AMA Style
Gawęda W, Pruszyński M, Cędrowska E, Rodak M, Majkowska-Pilip A, Gaweł D, Bruchertseifer F, Morgenstern A, Bilewicz A.
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials. 2020; 10(10):2067.
https://doi.org/10.3390/nano10102067
Chicago/Turabian Style
Gawęda, Weronika, Marek Pruszyński, Edyta Cędrowska, Magdalena Rodak, Agnieszka Majkowska-Pilip, Damian Gaweł, Frank Bruchertseifer, Alfred Morgenstern, and Aleksander Bilewicz.
2020. "Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy" Nanomaterials 10, no. 10: 2067.
https://doi.org/10.3390/nano10102067
APA Style
Gawęda, W., Pruszyński, M., Cędrowska, E., Rodak, M., Majkowska-Pilip, A., Gaweł, D., Bruchertseifer, F., Morgenstern, A., & Bilewicz, A.
(2020). Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials, 10(10), 2067.
https://doi.org/10.3390/nano10102067